Skye Bioscience, Inc. Common Stock (SKYE) is a publicly traded Healthcare sector company. As of November 10, 2026, SKYE trades at $0.76 with a market cap of $4.38M and a P/E ratio of -1.17. SKYE moved +17.38% today. Year to date, SKYE is -89.05%; over the trailing twelve months it is -93.72%. Its 52-week range spans $0.51 to $46.00. Rallies surfaces SKYE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Skye Bioscience, Inc. Common Stock (SKYE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SKYE moved +17.38% today.
| Metric | Value |
|---|---|
| Price | $0.76 |
| Market Cap | $4.38M |
| P/E Ratio | -1.17 |
| EPS | $-1.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.00 |
| 52-Week Low | $0.51 |
| Volume | 1.46M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-55.92M |
| Gross Margin | 0.00% |
SKYE analyst coverage data. Average price target: $0.00.